Dalkh, T. et al. 2018. Effects of Hepaclin-4 on Hepatocellular Carcinoma (Hep G2). Central Asian Journal of Medical Sciences. 4, 1 (Mar. 2018), 48–54. DOI:https://doi.org/10.24079/cajms.2018.03.006.